UPDATE 1-Dynavax's hep B vaccine meets goals in late-stage study
January 07, 2016 at 07:44 AM EST
Jan 7 (Reuters) - Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study, sending its shares up 9.4 percent in premarket trading.
